Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

Contact Us

Search

chronic spontaneous urticaria

Immunology

Immunology Today—January 8, 2026

This Immunology update captures a broad range of developments, including…

Immunology

Immunology Video Recap—December 3, 2025

This biweekly immunology video highlights major regulatory wins, evolving…

Immunology

Immunology Today—November 26, 2025

This week’s Immunology update spotlights key developments, regulatory…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Public Health Today—16 January, 2026
Respiratory Today—January 16, 2026
Vaccines Today—January 16, 2026
Lucid Diligence Brief: Ocugen preliminary Phase 2 data in geographic atrophy
Cardiovascular Video Recap—January 15, 2026

Tags

AAVantgarde Acella acquired hemophilia A ADHAND AI in biopharma AMWC Dubai BRAF V600 Cigna coverage Clinical AI scribes CTNNB1S37F Diabetic retinopathy DMD exon 51 Ebola Ecnoglutide EFX EMA CHMP Endeavor BioMedicines Evolocumab (Repatha) GLP 1 Access Henlius INESSS MASLD Merck KEYTRUDA mirikizumab molgramostim neuroimaging ofatumumab OpenAI Oral incretins PCV13 booster PDPL pharma dealmaking Plus Therapeutics Pulmonary tuberculosis R9 Relief Cardiovascular SERD SLE STAR-101 Subretinal delivery TEER-ineligible The Lancet TranC Waldenström macroglobulinemia Xinermei

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Public Health Today—16 January, 2026
Respiratory Today—January 16, 2026
Vaccines Today—January 16, 2026
Lucid Diligence Brief: Ocugen preliminary Phase 2 data in geographic atrophy
Cardiovascular Video Recap—January 15, 2026

TAGS

AAVantgarde Acella acquired hemophilia A ADHAND AI in biopharma AMWC Dubai BRAF V600 Cigna coverage Clinical AI scribes CTNNB1S37F Diabetic retinopathy DMD exon 51 Ebola Ecnoglutide EFX EMA CHMP Endeavor BioMedicines Evolocumab (Repatha) GLP 1 Access Henlius INESSS MASLD Merck KEYTRUDA mirikizumab molgramostim neuroimaging ofatumumab OpenAI Oral incretins PCV13 booster PDPL pharma dealmaking Plus Therapeutics Pulmonary tuberculosis R9 Relief Cardiovascular SERD SLE STAR-101 Subretinal delivery TEER-ineligible The Lancet TranC Waldenström macroglobulinemia Xinermei

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy